Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Tepper Robert I
Relationship:   10% Owner
City:   Cambridge,
State:   MA
   
Insider Summary:
  
   
Companies Owned :   23    
Direct Shares   39,892,982    

Indirect Shares

   23,508,369      
Direct Value   $791,326,064    

Indirect Value

   $518,196,485      
Total Shares   63,401,351      
Total Value   $1,309,522,548      


Millennium Pharmaceuticals Inc $0 Bluebird Bio, Inc. $83,685 Dare Bioscience Inc $7,735 Sage Therapeutics, Inc. $0 Blueprint Medicines Corp $385,998,229 Global Blood Therapeutics, Inc. $15,737,153 Cytomx Therapeutics, Inc. $0 Voyager Therapeutics, Inc. $26,205,164 Editas Medicine, Inc. $20,780,856 Rhythm Pharmaceuticals, Inc. $144,167,834 Allena Pharmaceuticals, Inc. $3 Fulcrum Therapeutics, Inc. $0 Revolution Medicines, Inc. $198,345,405 Nurix Therapeutics, Inc. $0 Decibel Therapeutics, Inc. $0 Pliant Therapeutics, Inc. $0 Millennium Pharmaceuticals Inc $0 Bluebird Bio, Inc. $83,685 Dare Bioscience Inc $7,735 Sage Therapeutics, Inc. $0 Blueprint Medicines Corp $385,998,229 Global Blood Therapeutics, Inc. $15,737,153 Cytomx Therapeutics, Inc. $0 Voyager Therapeutics, Inc. $26,205,164 Editas Medicine, Inc. $20,780,856 Rhythm Pharmaceuticals, Inc. $144,167,834 Allena Pharmaceuticals, Inc. $3 Fulcrum Therapeutics, Inc. $0 Revolution Medicines, Inc. $198,345,405 Nurix Therapeutics, Inc. $0 Decibel Therapeutics, Inc. $0 Pliant Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    15    

     Stock price went up :
    0   
    7    
     Stock price went down :
    0   
    8    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
 239.8%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Millennium Pharmaceuticals Inc MLNM President, R&D 2007-02-12 105,137 2007-02-12 7,116    Premium*  
            Bluebird Bio, Inc. BLUE Director, 10% Owner 2015-02-03 89,017 2015-02-03 0    Premium*  
            Carisma Therapeutics Inc CARM 10% Owner 0 2014-02-05 330,708    Premium*  
            Dare Bioscience Inc DARE Director 2014-04-10 18,954 0    Premium*  
            Sage Therapeutics, Inc. SAGE 10% Owner 2016-08-19 3,170,750 2015-01-16 0    Premium*  
            Larimar Therapeutics Inc LRMR 10% Owner 2015-07-23 0 2015-03-24 0    Premium*  
            Foundation Medicine, Inc. FMI 10% Owner 2015-05-14 0 0    Premium*  
            Blueprint Medicines Corp BPMC 10% Owner 2017-02-27 3,770,987 0    Premium*  
            Global Blood Therapeutics, Inc. GBT 10% Owner 2017-04-06 229,773 2017-04-06 4,760,904    Premium*  
            Cytomx Therapeutics, Inc. CTMX 10% Owner 2017-10-18 3,668,070 2017-10-04 4,320,348    Premium*  
            Voyager Therapeutics, Inc. VYGR 10% Owner 2023-02-02 3,271,556 0    Premium*  
            Editas Medicine, Inc. EDIT 10% Owner 2016-08-16 3,906,176 2016-02-08 0    Premium*  
            Jounce Therapeutics Inc JNCE Director, 10% Owner 2017-02-01 0 2017-02-01 3,048,780    Premium*  
            Kala Pharmaceuticals, Inc. KALA Director 2017-07-25 0 2017-07-25 1,621,092    Premium*  
            Rhythm Pharmaceuticals, Inc. RYTM 10% Owner 2017-10-10 3,981,437 2017-10-10 0    Premium*  
            Allena Pharmaceuticals, Inc. ALNA Director, 10% Owner 2017-11-06 2,790,964 2017-11-06 0    Premium*  
            Neon Therapeutics, Inc. NTGN Director, 10% Owner 2018-06-29 0 2020-05-06 0    Premium*  
            Constellation Pharmaceuticals Inc CNST Director, 10% Owner 2018-07-23 0 2018-08-22 3,034,083    Premium*  
            Fulcrum Therapeutics, Inc. FULC 10% Owner 2022-12-13 2,118,391 2022-12-13 2,343,154    Premium*  
            Revolution Medicines, Inc. RVMD 10% Owner 2022-06-08 5,233,388 2020-09-09 1,909,317    Premium*  
            Nurix Therapeutics, Inc. NRIX 10% Owner 2020-07-28 5,422,549 2020-07-28 0    Premium*  
            Decibel Therapeutics, Inc. DBTX 10% Owner 2021-02-11 47,169 0    Premium*  
            Pliant Therapeutics, Inc. PLRX 10% Owner 2022-11-29 2,068,664 2022-11-29 2,132,867    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
GBT Global Blood Therapeutics... 10% Owner   –       –       •   2015-08-17 4 A $0.00 $0 D/D 11,903,763 12,475,191 0 -
VYGR Voyager Therapeutics, Inc... 10% Owner   –       –       •   2015-11-16 4 A $0.00 $0 D/D 10,588,235 11,061,176 0 -
VYGR Voyager Therapeutics, Inc... 10% Owner   –       –       •   2016-12-19 4 D $0.00 $0 D/D (750,000) 10,311,176 0 -
VYGR Voyager Therapeutics, Inc... 10% Owner   –       –       •   2017-04-12 4 AS $0.00 $0 D/D (920,000) 9,391,176 0 -
CTMX Cytomx Therapeutics, Inc. 10% Owner   –       –       •   2015-10-14 4 A $0.00 $0 D/D 8,670,351 8,670,351 0 -
RVMD Revolution Medicines, Inc... 10% Owner   –       –       •   2020-09-09 4 D $0.00 $0 D/D (1,000,000) 8,024,031 0 -
VYGR Voyager Therapeutics, Inc... 10% Owner   –       –       •   2018-06-20 4 AS $0.00 $0 D/D (1,500,000) 7,891,176 0 -
CTMX Cytomx Therapeutics, Inc. 10% Owner   –       –       •   2016-11-07 4 D $0.00 $0 D/D (1,000,000) 7,670,348 0 -
GBT Global Blood Therapeutics... 10% Owner   –       –       •   2016-12-14 4 AS $0.00 $0 D/D (2,000,000) 7,475,191 0 -
BPMC Blueprint Medicines Corp 10% Owner   –       –       •   2015-05-05 4 A $0.00 $0 D/D 7,120,332 7,393,059 0 -
CTMX Cytomx Therapeutics, Inc. 10% Owner   –       –       •   2017-03-15 4 AS $0.00 $0 D/D (850,000) 6,820,348 0 -
VYGR Voyager Therapeutics, Inc... 10% Owner   –       –       •   2018-09-19 4 AS $0.00 $0 D/D (1,500,000) 6,391,176 0 -
VYGR Voyager Therapeutics, Inc... 10% Owner   –       –       •   2022-08-12 4 S $6.12 $2,129,803 D/D (348,007) 6,043,169 0 %
FULC Fulcrum Therapeutics, Inc... 10% Owner   –       –       •   2019-07-22 4 B $16.00 $1,300,000 D/D 81,250 5,962,202 2.45 -
VYGR Voyager Therapeutics, Inc... 10% Owner   –       –       •   2022-08-15 4 S $6.04 $820,280 D/D (135,808) 5,907,361 0 %
FULC Fulcrum Therapeutics, Inc... 10% Owner   –       –       •   2019-07-22 4 A $0.00 $0 D/D 5,595,238 5,880,952 0 -
CTMX Cytomx Therapeutics, Inc. 10% Owner   –       –       •   2017-03-23 4 S $17.00 $17,000,200 D/D (1,000,000) 5,820,348 0 -
VYGR Voyager Therapeutics, Inc... 10% Owner   –       –       •   2022-08-16 4 S $6.04 $775,874 D/D (128,456) 5,778,905 0 %
VYGR Voyager Therapeutics, Inc... 10% Owner   –       –       •   2022-08-24 4 S $6.09 $913,329 D/D (149,972) 5,628,933 0 %
BPMC Blueprint Medicines Corp 10% Owner   –       –       •   2016-04-14 4 D $0.00 $0 D/D (1,200,000) 5,453,753 0 -
VYGR Voyager Therapeutics, Inc... 10% Owner   –       –       •   2022-08-25 4 S $6.22 $1,244,000 D/D (200,000) 5,428,933 0 %
NRIX Nurix Therapeutics, Inc. 10% Owner   –       –       •   2020-07-28 4 A $0.00 $0 D/D 5,422,549 5,422,549 0 -
VYGR Voyager Therapeutics, Inc... 10% Owner   –       –       •   2023-01-20 4 S $9.15 $915,000 D/D (100,000) 5,328,933 0 %
VYGR Voyager Therapeutics, Inc... 10% Owner   –       –       •   2023-01-23 4 S $9.06 $498,300 D/D (55,000) 5,273,933 0 %
VYGR Voyager Therapeutics, Inc... 10% Owner   –       –       •   2023-01-24 4 S $9.27 $927,000 D/D (100,000) 5,173,933 0 %
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us